Stock PBH PRESTIGE CONSUMER HEALTHCARE INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Prestige Consumer Healthcare Inc.

Equities

PBH

US74112D1019

Market Closed - Nyse
Other stock markets
 04:00:01 2024-04-16 pm EDT 		5-day change 1st Jan Change
68.06 USD -0.12% Intraday chart for Prestige Consumer Healthcare Inc. -1.62% +11.17%
Feb. 16 Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing MT
Feb. 16 Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
GL
Prestige Consumer Healthcare : Consumer Analyst Group of New York (CAGNY) 2024 Luncheon Presentation
PU
Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing
MT
Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing
MT
Prestige Consumer Healthcare Insider Sold Shares Worth $368,184, According to a Recent SEC Filing
MT
Prestige Consumer Healthcare's Fiscal Q3 Earnings, Revenue Increase; Raises 2024 Earnings Guidance; Shares Gain
MT
Transcript : Prestige Consumer Healthcare Inc., Q3 2024 Earnings Call, Feb 08, 2024
North American Morning Briefing : S&P 500 to Open -2-
DJ
Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q3 Revenue $282.7M, vs. Street Est of $280.4M
MT
Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q3 EPS $1.06, vs. Street Est of $1.04
MT
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot
AQ
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
GL
Prestige Consumer Healthcare Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Prestige Consumer Healthcare Inc. Revises Earnings Guidance for the Year of Fiscal 2024
CI
Prestige Consumer Healthcare Unit Recalls 2 Lots of Ting Antifungal Spray Liquid on High Levels of Benzene
MT
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
GL
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
AQ
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
GL
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
AQ
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PBH Stock
  4. News Prestige Consumer Healthcare Inc.